EHNA

From WikiMD's WELLNESSPEDIA

File:EHNA.svg
EHNA structure

EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]

References[edit]

  1. Sigma Aldrich(link). {{{website}}}.
  2. "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine".Cell Signal.1995;7(7)
    733–8.doi:10.1016/0898-6568(95)00042-N.PMID:8519602.
  3. "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes".Mol Pharmacol.1995;48(1)
    121–130.PMID:7623766.


This article is a stub related to pharmacology. You can help WikiMD by expanding it!